Abstract
Melanoma is the most aggressive form of skin cancer, early diagnosis and treatment are critical for determining treatment outcomes. Traditional diagnostic methods, such as clinical examination, dermoscopy, and histopathology, provide valuable insights but are limited by subjectivity and interobserver variability. Artificial intelligence (AI), particularly convolutional neural networks, has shown strong potential to enhance melanoma detection, offering accuracy comparable to dermatologists. This review summarizes current and emerging applications of AI in melanoma diagnosis, covering diagnostic tools, educational systems, and smartphone-based apps. Despite encouraging results, challenges such as interpretability, data bias, regulatory hurdles, and ethical issues remain. Integrating AI into clinical workflows, supported by diverse and validated datasets, could significantly improve early therapeutic interventions and patient management.
| Original language | English |
|---|---|
| Pages (from-to) | 69-78 |
| Number of pages | 10 |
| Journal | Journal of Applied Pharmaceutical Science |
| Volume | 16 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 04-2026 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Medicine (miscellaneous)
- General Pharmacology, Toxicology and Pharmaceutics
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'Emerging role of artificial intelligence in melanoma diagnosis: Implications for clinical and therapeutic management'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver